Alliances
Please check out the biopharma industry’s COVID-19 stories that are trending for May 11, 2021.
BioNTech will open a state-of-the-art manufacturing facility in Singapore to support a global supply of mRNA-based vaccines and therapeutics.
Biopharmaceutical company CRISPR Therapeutics has entered into a strategic research, development and commercialization partnership with cancer-focused Nkarta.
Please check out the biopharma industry’s COVID-19 stories that are trending for May 4, 2021.
One year after Astellas and California-based Cytokinetics extended an agreement to develop Skeletal Sarcomere Activators, the Japanese pharma company is walking away from the deal.
Please check out the biopharma industry’s COVID-19 stories that are trending for April 27, 2021.
Molecular Partners announced yesterday it has filed for a $100 million initial public offering with the Securities and Exchange Commission in the U.S., funding which will go toward supporting the company’s work in the development of protein-based treatments for COVID-19 and various cancers.
Please check out the biopharma industry’s COVID-19 stories that are trending for April 20, 2021.
Under the terms of the expanded deal, Vertex will be responsible for 60% of the costs of developing, manufacturing and commercializing CTX001 with support from CRISPR Therapeutics, and will receive 60% of profits from global sales.
The companies also plan to develop the candidate for the treatment of other potential future viral diseases.
PRESS RELEASES